沃戈宁
结肠炎
药理学
炎症性肠病
汉方
肠上皮
肠杆菌科
化学
医学
黄芩
微生物学
内科学
生物
免疫学
生物化学
上皮
大肠杆菌
中医药
病理
基因
疾病
替代医学
作者
Yu‐Lin Su,Junjie Liang,Meiling Zhang,Meng Zhao,Xueqian Xie,Xiaojing Wang,Zengfeng Pan,Shaowei Huang,Rong Yan,Qing Wang,Lian Zhou,Xia Luo
摘要
To investigate the potential effects and mechanism of wogonin on dextran sulfate sodium (DSS)-induced colitis, 70 male mice were administered wogonin (12.5, 25, 50 mg·kg-1 ·d-1 , i.g.) for 10 days, meanwhile, in order to induce colitis, the mice were free to drink 3% DSS for 6 days. We found that wogonin could obviously ameliorate DSS-induced colitis, including preventing colon shortening and inhibiting pathological damage. In addition, wogonin could increase the expression of PPARγ, which not only restores intestinal epithelial hypoxia but also inhibits iNOS protein to reduce intestinal nitrite levels. All these effects facilitated a reduction in the abundance of Enterobacteriaceae in DSS-induced colitis mice. Therefore, compared with the DSS group, the number of Enterobacteriaceae in the intestinal flora was significantly reduced after administration of wogonin or rosiglitazone by 16s rDNA technology. We also verified that wogonin could promote the expression of PPARγ mRNA and protein in Caco-2 cells, and this effect disappeared when PPARγ signal was inhibited. In conclusion, our study suggested that wogonin can activate the PPARγ signal of the Intestinal epithelium to ameliorate the Intestinal inflammation caused by Enterobacteriaceae bacteria expansion.
科研通智能强力驱动
Strongly Powered by AbleSci AI